FDA Import Refusal AEK-2139130-4/10002/1A — Daewoong Pharmaceutical
The FDA refused shipment AEK-2139130-4/10002/1A from Daewoong Pharmaceutical (South Korea) on Oct 2, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charges: 333,336,75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Oct 2, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 58PCZ05 ONABOTULINUMTOXINA
- Charges
- 333,336,75